Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Burgart YV, Agafonova NA, Shchegolkov EV, Krasnykh OP, Kushch SO, Evstigneeva NP, Gerasimova NA, Maslova VV, Triandafilova GA, Solodnikov SY, Ulitko MV, Makhaeva GF, Rudakova EV, Borisevich SS, Zilberberg NV, Kungurov NV, Saloutin VI, Chupakhin ON. Burgart YV, et al. Among authors: kungurov nv. Eur J Med Chem. 2020 Dec 15;208:112768. doi: 10.1016/j.ejmech.2020.112768. Epub 2020 Aug 23. Eur J Med Chem. 2020. PMID: 32932211
Promising Antifungal and Antibacterial Agents Based on 5-Aryl-2,2'-bipyridines and Their Heteroligand Salicylate Metal Complexes: Synthesis, Bioevaluation, Molecular Docking.
Burgart Y, Shchegolkov E, Shchur I, Kopchuk D, Gerasimova N, Borisevich S, Evstigneeva N, Zyryanov G, Savchuk M, Ulitko M, Zilberberg N, Kungurov N, Saloutin V, Charushin V, Chupakhin O. Burgart Y, et al. ChemMedChem. 2022 Feb 4;17(3):e202100577. doi: 10.1002/cmdc.202100577. Epub 2021 Nov 26. ChemMedChem. 2022. PMID: 34783161
Synthesis and biological evaluation of novel 5-aryl-4-(5-nitrofuran-2-yl)-pyrimidines as potential anti-bacterial agents.
Verbitskiy EV, Baskakova SA, Gerasimova NA, Evstigneeva NP, Zil'berberg NV, Kungurov NV, Kravchenko MA, Skornyakov SN, Pervova MG, Rusinov GL, Chupakhin ON, Charushin VN. Verbitskiy EV, et al. Among authors: kungurov nv. Bioorg Med Chem Lett. 2017 Jul 1;27(13):3003-3006. doi: 10.1016/j.bmcl.2017.05.013. Epub 2017 May 6. Bioorg Med Chem Lett. 2017. PMID: 28512023
Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV, Slepukhin PA, Kravchenko MA, Skornyakov SN, Evstigneeva NP, Kungurov NV, Zil'berberg NV, Rusinov GL, Chupakhin ON, Charushin VN. Verbitskiy EV, et al. Among authors: kungurov nv. Bioorg Med Chem Lett. 2015 Feb 1;25(3):524-8. doi: 10.1016/j.bmcl.2014.12.025. Epub 2014 Dec 16. Bioorg Med Chem Lett. 2015. PMID: 25556103
Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.
Baranauskaite A, Raffayová H, Kungurov NV, Kubanova A, Venalis A, Helmle L, Srinivasan S, Nasonov E, Vastesaeger N; RESPOND investigators. Baranauskaite A, et al. Among authors: kungurov nv. Ann Rheum Dis. 2012 Apr;71(4):541-8. doi: 10.1136/ard.2011.152223. Epub 2011 Oct 12. Ann Rheum Dis. 2012. PMID: 21994233 Free PMC article. Clinical Trial.